Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-12-01T00:12:46.777Z Has data issue: false hasContentIssue false
  • English
  • Français

Plasma adiponectin levels and relations with cytokines in children with acute rheumatic fever

Published online by Cambridge University Press:  16 June 2014

Huriye Ozgen ,
Birsen Ucar ,
Ali Yildirim ,
Omer Colak ,
Cengiz Bal  and
Zubeyir Kilic
Huriye Ozgen
Affiliation:
Medical Faculty, Department of Pediatric Cardiology, Eskisehir Osmangazi University, Eskisehir, Turkey
Birsen Ucar
Affiliation:
Medical Faculty, Department of Pediatric Cardiology, Eskisehir Osmangazi University, Eskisehir, Turkey
Ali Yildirim*
Affiliation:
Medical Faculty, Department of Pediatric Cardiology, Eskisehir Osmangazi University, Eskisehir, Turkey
Omer Colak
Affiliation:
Medical Faculty, Department of Biochemistry, Eskisehir Osmangazi University, Eskisehir, Turkey
Cengiz Bal
Affiliation:
Medical Faculty, Department of Biostatistics, Eskisehir Osmangazi University, Eskisehir, Turkey
Zubeyir Kilic
Affiliation:
Medical Faculty, Department of Pediatric Cardiology, Eskisehir Osmangazi University, Eskisehir, Turkey
*
Correspondence to: Dr A. Yildirim, Eskisehir Osmangazi Üniversitesi, Tıp Fakultesi, Pediatrik Kardiyoloji Bilim Dalı, 26480, Eskisehir, Turkey. Tel: +9 0 530 882 2319 (GSM); Fax: +9 0 222 239 2979/7440; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Aim: We aimed to investigate the role of adiponectin in acute rheumatic fever by evaluating correlations with cytokines and acute-phase reactants. Methods: Patients were divided into three groups by clinical findings. Group 1 included 8 patients with only chorea, Group 2 included 13 patients with arthritis and carditis, and Group 3 included 12 patients with only carditis. A total of 54 age- and gender-matched children were enrolled in the control group. Blood samples were drawn for analysing acute-phase reactants, adiponectin, tumour necrosis factor-α, interleukin-6, and interleukin-8 levels at baseline on Days 2, 5, 10, and 15, and at 8 weeks. Results: There was no statistically significant difference between baseline age, gender, body mass index, serum triglyceride, total cholesterol, and low-density lipoprotein levels of the study and control groups (p>0.05). No correlation was found between baseline plasma adiponectin levels, age, body mass index, follicle-stimulating hormone, luteinising hormone, oestradiol, total testosterone, and blood lipid levels of the study and control groups (p>0.05). We found that adiponectin and interleukin-6 levels increased, tumour necrosis factor-α levels decreased, and interleukin-8 levels remained unchanged in acute rheumatic fever, which is an inflammatory disease. Moreover, adiponectin level was higher and tumour necrosis factor-α level was lower in the improvement period in comparison with the acute period, particularly in the carditis group. Conclusion: It was considered that, increasing throughout the treatment period, adiponectin may have anti-inflammatory effects in acute rheumatic fever. In addition, adiponectin levels are associated with a decline in inflammatory mediators in rheumatic fever.

Keywords

Adiponectincytokinesacute rheumatic fever
Type
Original Articles
Information
Cardiology in the Young , Volume 25 , Issue 5 , June 2015 , pp. 879 - 892
Copyright
© Cambridge University Press 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Ortiz, EE. Acute rheumatic fever. In: Anderson RH, Baker EJ,Macartney FJ, RigbyML, Shinebourne EA, Tynan M (eds). Paediatric Cardiology, vol. 2, 2nd edn. Churchill Livingstone, London, 2002: 1713–1731.Google Scholar
2. Ayoub, EM. Acute rheumatic fever. In: Allen HD, Shaddy RE, Feltes TF, Driscoll DJ (eds). Moss and Adams’ Heart Disease in Infants, Children and Adolescents, 7th edn. Lippincott Williams and Wilkins, Philadelphia, 2008: 1256–1280.Google Scholar
3. Cilliers, AM. Rheumatic fever and its management. BMJ 2006; 333: 1153–1156.Google Scholar
4. Dajani, AS, Ayoub, E, Bierman, FZ, et al. Guidelines for the diagnosis of acute rheumatic fever. Jones criteria 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. JAMA 1992; 268: 2069–2073.Google Scholar
5. Ferreri, P. Proceedings of the Jones criteria workshop. Circulation 2002; 106: 2521–2523.Google Scholar
6. Matsuwaza, Y. Adiponectin: identification, physiology and clinical relevance in metabolic and vascular disease. Atheroscler Suppl 2005; 6: 7–14.CrossRefGoogle Scholar
7. Guzik, TJ, Mangalat, D, Korbut, R. Adipocytokines-novel link between inflammation and vascular function? J Physiol Pharmacol 2006; 57: 505–528.Google ScholarPubMed
8. Tilg, H, Moschen, AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immnol 2006; 6: 772–783.Google Scholar
9. Ryo, M, Nakamura, T, Kihara, S. Adiponectin as a biomarker of the metabolic syndrome. Circ J 2004; 68: 975–981.Google Scholar
10. Fallo, F, Scarda, A, Sonino, N, et al. Effect of glucocorticoids on adiponectin: a study in healthy subjects and in Cushing’s syndrome. Eur J Endocrinol 2004; 150 339–344.Google Scholar
11. Takeshita, S, Takabayashi, H, Yoshida, N. Circulating adiponectin levels in Kawasaki Disease. Clin Observ 2006: 1312–1314.Google ScholarPubMed
12. Senolt, L, Pavelka, K, Housa, D, Haluzík, M. Increased adiponectin is negatively linked to the local inflammatory process in patients with rheumatoid arthritis. Cytokine 2006; 35 247–252.Google Scholar
13. Elenkov, IJ, Chrousos, GP. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci 2002; 966: 290–303.Google Scholar
14. Zedan, MM, el-Shennawy, FA, Abou-Bakr, HM, al-Basousy, AM. Interleukin-2 in relation to T cell subpopulations in Rheumatic heart disease. Arch Dis Child 1992; 67: 1373–1375.Google Scholar
15. Miller, LC, Gray, ED, Mansour, M, et al. Cytokines and immunoglobulin in rheumatic heart disease: production by blood and tonsillar mononuclear cells. J Rheumatol 1989; 16: 1436–1442.Google Scholar
16. Morris, K, Mohan, C, Wahi, PL, Anand, IS, Ganguly, NK. Enhancement of IL-1, IL-2 production and IL-2 receptor generation in patients with acute rheumatic fever and active rheumatic heart disease; a prospective study. Clin Exp Immunol 1993; 91: 429–436.Google Scholar
17. Narin, N, Kütükçüler, N, Özyürek, R, Bakiler, AR, Parlar, A, Arcasoy, M. Lymphocyte subsets and plasma IL-1 alpha, IL-2, and TNF-α concentrations in acute rheumatic fever and chronic rheumatic heart disease. Clin Immunol Immunopathol 1995; 77: 172–176.Google Scholar
18. Yegin, O, Coskun, M, Ertug, H. Cytokines in acute rheumatic fever. Eur J Pediatr 1997; 156: 25–29.Google Scholar
19. Kütükçüler, N, Narin, N. Plasma interleukin-7 (IL-7) and IL-8 concentrations in acute rheumatic fever and chronic rheumatic heart disease. Scand J Rheumatol 1995; 24: 383–385.Google Scholar
20. Lawlor, DA, Smith, GD, Ebrahim, S. Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women. J Clin Endocrinol Metab 2005; 90: 5677–5683.Google Scholar
21. Panamonta, M, Settasatian, N, Kaplan, EL, Chaikitpinyo, A. Serum cholesterol levels in patients with acute rheumatic fever. American J of Diseases of Children 1993; 147: 732–736.Google Scholar
22. Ouchi, N, Walsh, K. Adiponectin as an anti-inflammatory factor. Clinica Chimica Acta 2007; 380: 24–30.Google Scholar
23. Ogawa, Y, Kikuchi, T, Nagasaki, K, Hiura, M, Tanaka, Y, Uchiyama, M. Usefulness of serum adiponectin level as a diagnostic marker of metabolic syndrome in obese Japanese children. Hypertens Res 2005; 28: 51–57.Google Scholar
24. Ko, GT, So, WY, Tong, P, et al. Hypoadiponectinaemia enhances waist circumference as a predictor of glucose intolerance and clustering of risk factors in Chinese men. Diabetes Metab 2010; 36: 192–197.CrossRefGoogle ScholarPubMed
25. Vitoratos, N, Deliveliotou, A, Vlahos, NF, et al. Serum adiponectin during pregnancy and postpartum in women with gestational diabetes and normal controls. Gynecol Endocrinol 2008; 24: 614–619.Google Scholar
26. Tsuchihashi, H, Yamamoto, H, Maeda, K, et al. Circulating concentrations of adiponectin, an endogenous lipopolysaccharide neutralizing protein, decrease in rats with polymicrobial sepsis. J Surg Res 2006; 134: 348–353.Google Scholar
27. Fantuzzi, G. Adiponectin and inflammation: consensus and controversy. J Allergy Clin Immunol 2008; 121: 326–330.Google Scholar
28. Schaffler, A, Ehling, A, Neumann, E, Herfarth, H, Tarner, I, Scholmerich, J. Adipocytokines in synovial fluid. JAMA 2003; 290: 09–10.Google Scholar
29. Chen, TH, Chen, L, Hsieh, MS, Chang, CP, Chou, DT, Tsai, SH. Evidence for a protective role for adiponectin in osteoarthritis. Biochim Biophys Acta 2006; 1762: 711–718.Google Scholar
30. Fayad, R, Pini, M, Sennello, JA, et al. Adiponectin deficiency protects mice from chemically induced colonic inflammation. Gastroenterology 2007; 132: 601–614.Google Scholar
31. Shore, SA, Terry, RD, Flynt, L, Xu, A, Hug, C. Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice. J Allergy Clin Immunol 2006; 118: 389–395.Google Scholar
32. Rothenbacher, D, Weyermann, M, Fantuzzi, G, Brenner, H. Adipokines in cord blood and risk of wheezing disorders within the first two years of life. Clin Exp Allergy 2007; 37: 1143–1149.CrossRefGoogle ScholarPubMed
33. Lee, SW, Kim, JH, Park, MC, Park, YB, Lee, SK. Adiponectin mitigates the severity of arthritis in mice with collagen-induced arthritis. Scand J Rheumatol 2008; 37: 260–268.Google Scholar
34. Kitahara, K, Kusunoki, N, Kakiuchi, T, Suguro, T, Kawai, S. Adiponectin stimulates IL-8 production by rheumatoid synovial fibroblasts. Biochem Biophys Res Commun 2009; 378: 218–223.Google Scholar